| Entry |
|
|---|
| Name |
Etoposide phosphate (USAN);
Etopophos (TN) |
|---|
| Product |
|
|---|
| Formula |
C29H33O16P
|
|---|
| Exact mass |
668.1506
|
|---|
| Mol weight |
668.5365
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antineoplastic
DG01529 Topoisomerase inhibitor
DG01527 Topoisomerase II inhibitor
|
|---|
| Remark |
| Product (DG00693): | D00125<JP/US> D04107<US> |
|
|---|
| Efficacy |
Antineoplastic, Topoisomerase II inhibitor |
|---|
| Disease |
Testicular tumors [DS: H00023] Small cell lung cancer [DS: H00013] |
|---|
| Target |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07042 | Antineoplastics - agents from natural products |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
L01CB Podophyllotoxin derivatives
L01CB01 Etoposide
D04107 Etoposide phosphate (USAN) <US>
USP drug classification [BR:br08302]
Antineoplastics
Molecular Target Inhibitors
Etoposide
D04107 Etoposide phosphate (USAN)
Drug groups [BR:br08330]
Antineoplastic
DG01529 Topoisomerase inhibitor
DG01527 Topoisomerase II inhibitor
DG00693 Etoposide
D04107 Etoposide phosphate
Target-based classification of drugs [BR:br08310]
Enzymes
Isomerases (EC5)
DNA topoisomerase
TOP2
D04107 Etoposide phosphate (USAN) <US>
Drug groups [BR:br08330]
Antineoplastic
DG01529 Topoisomerase inhibitor
DG01527 Topoisomerase II inhibitor
DG00693 Etoposide
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 46
1 C8y C 27.7376 -18.0842
2 C8y C 27.7376 -19.4861
3 C8x C 28.9516 -20.1870
4 C8y C 30.1657 -19.4861
5 C8y C 30.1657 -18.0842
6 C8x C 28.9516 -17.3833
7 C1y C 31.3797 -20.1870
8 C1y C 32.5937 -19.4861
9 C1y C 32.5937 -18.0842
10 C1y C 31.3797 -17.3833
11 O2x O 26.4042 -17.6511
12 C1x C 25.5803 -18.7851
13 O2x O 26.4042 -19.9193
14 C7x C 33.9269 -19.9193
15 O7x O 34.7510 -18.7851
16 C1x C 33.9269 -17.6511
17 O6a O 34.3542 -21.2348
18 C8y C 31.3797 -21.5888
19 C8x C 30.1677 -22.2886
20 C8y C 30.1677 -23.6904
21 C8y C 31.3817 -24.3914
22 C8y C 32.5937 -23.6916
23 C8x C 32.5937 -22.2898
24 O2a O 28.9706 -24.3818
25 O2a O 33.7929 -24.3841
26 C1a C 34.9828 -23.6971
27 C1a C 27.7827 -23.6960
28 O2b O 31.3817 -25.7944
29 O2a O 31.3797 -15.9814
30 C1y C 30.1677 -15.2817
31 C1y C 30.1677 -13.8788
32 C1y C 28.9536 -13.1779
33 C1y C 27.7396 -13.8788
34 C1y C 27.7396 -15.2817
35 O2x O 28.9537 -15.9826
36 O2x O 26.5255 -13.1779
37 C1y C 25.3114 -13.8788
38 O2x O 25.3114 -15.2817
39 C1x C 26.5255 -15.9826
40 O1a O 28.9536 -11.7760
41 C1a C 24.0771 -13.1660
42 O1a O 31.3990 -13.1677
43 P1b P 32.5725 -26.4816
44 O1c O 33.7854 -27.1819
45 O1c O 33.2751 -25.2645
46 O1c O 31.8749 -27.6900
BOND 52
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 1 11 1
13 11 12 1
14 12 13 1
15 2 13 1
16 8 14 1
17 14 15 1
18 15 16 1
19 9 16 1
20 14 17 2
21 7 18 1 #Down
22 18 19 2
23 19 20 1
24 20 21 2
25 21 22 1
26 22 23 2
27 18 23 1
28 20 24 1
29 22 25 1
30 25 26 1
31 24 27 1
32 21 28 1
33 10 29 1 #Up
34 30 29 1 #Down
35 30 31 1
36 31 32 1
37 32 33 1
38 33 34 1
39 34 35 1
40 30 35 1
41 33 36 1
42 36 37 1
43 37 38 1
44 38 39 1
45 34 39 1
46 32 40 1 #Down
47 37 41 1 #Up
48 31 42 1 #Up
49 28 43 1
50 43 44 1
51 43 45 2
52 43 46 1
|
|---|
